Stockreport

MiNK Therapeutics to Present Updated Data from Phase 2 Study Testing AgenT-797 in Gastric Cancer at AACR IO Annual Meeting [Yahoo! Finance]

MiNK Therapeutics, Inc.  (INKT) 
PDF Wed, February 12, 2025 at 7:00 PM GMT+1 3 min read In This Article INKT MiNK Therapeutics NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. [Read more]